Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

Impax introduces authorized generic of Zomig in US By PBR Staff Writer
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News
Almac secures BBSRC programme with UCL By PBR Staff Writer
UK-based Almac biocatalysis has secured a Biotechnology and Biological Sciences Research Council (BBSRC) programme with University College London (UCL) aimed at metagenomics and novel enzyme discovery.
Drug Research > Drug Discovery & Development > News Evotec, Harvard to jointly develop new class of antibacterials By PBR Staff Writer
Evotec and Harvard University have entered into research collaboration to develop new class of antibacterials.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
BioDuro opens laboratory in China
17 May 2013 | By PBR Staff Writer
BioDuro has opened a new laboratory in Shanghai to supply customized drug discovery services to biopharmaceutical clients in Asia Pacific.
Drug Research > Drug Discovery & Development > News
Mylan introduces generic version of Abbvie Tricor tablets
17 May 2013 | By PBR Staff Writer
Mylan Pharmaceuticals, the subsidiary of Mylan, has introduced Fenofibrate tablets, 48 mg and 145 mg.
Drug Research > Drug Discovery & Development > News
India develops new low-cost vaccine against diarrhea virus
15 May 2013 | By PBR Staff Writer
The Indian government has announced the development of new low-cost vaccine referred to as Rotavac against rotavirus, a diarrhea causative agent leading to a number of childhood deaths in the developing world.
Drug Research > Drug Discovery & Development > News
BioTrinity 2013 - European Biopartnering and Investment Conference - May 14-16, 2013
13 May 2013
BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other European partnering conference. Check out who else is coming, we expect about 850 delegates including nearly 80 investment firms, hear what delegates say about BioTrinity, the expert discussion panels, and which 90 companies will be presenting in the showcase.
Drug Research > Drug Discovery & Development > Press Releases
ALS-ETF, Denovo partner for Amyotrophic Lateral Sclerosis treatment
13 May 2013 | By PBR Staff Writer
The ALS Emergency Treatment Fund (ALS-ETF) and Denovo Biomarkers (Denovo) have entered into partnership to explore using Denovo's technology to identify potential responder groups for drugs that are being studied in patients suffering from Amyotrophic Lateral Sclerosis (ALS).
Drug Research > Drug Discovery & Development > News
Nimbus, Shire enter into co-development agreement for lysosomal storage disorders
10 May 2013 | By PBR Staff Writer
Nimbus Discovery, a US-based biotechnology company, has entered into a co-development agreement with Shire aiming at small molecule treatments for lysosomal storage disorders (LSDs), which are considered as the rare genetic diseases.
Drug Research > Drug Discovery & Development > News
GlaxoSmithKline Pharmaceuticals Q1 net income increases
08 May 2013 | By PBR Staff Writer
GlaxoSmithKline Pharmaceuticals in India has reported a net income from operations of Rs6.37bn ($118.06m) for the first quarter ended 31 March 2013 compared to Rs6.28bn ($116.39m) for the first quarter ended 31 March 2012.
Drug Research > Drug Discovery & Development > News
Ablynx commences pre-clinical development of allergic asthma candidate
08 May 2013 | By PBR Staff Writer
Ablynx has commenced pre-clinical development of ALX-0962, an anti- immunoglobulin E (IgE) nanobody, to treat severe allergic asthma and expects to begin Phase I development in the second half of 2014.
Drug Research > Drug Discovery & Development > News
Redx Pharma to open new R&D center in UK
08 May 2013 | By PBR Staff Writer
UK-based drug discovery and development company Redx Pharma is planning to open a new £10.5m research and development facility at AstraZeneca's Alderley Park site in Cheshire, England.
Drug Research > Drug Discovery & Development > News
GlaxoSmithKline announces funding from Wellcome Trust
07 May 2013 | By PBR Staff Writer
GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discover and develop the treatments for certain diseases.
Drug Research > Drug Discovery & Development > News
View all Drug Discovery & Development news or find news targeted to your interests

Buy the latest industry research online today!
African Pharmaceutical Directory 2013 01 February 2013 API research into pharmaceutical companies and corporations Buy online from $200